Neumann et al., 2013 - Google Patents
Variant TREM2 as risk factor for Alzheimer's diseaseNeumann et al., 2013
View PDF- Document ID
- 16465354759477201568
- Author
- Neumann H
- Daly M
- Publication year
- Publication venue
- New England Journal of Medicine
External Links
Snippet
Current knowledge about the pathogenic mechanism of Alzheimer's disease is based mainly on rare, high-penetrance variants in genes encoding amyloid precursor protein, presenilin 1, and presenilin 2, which result in familial early-onset Alzheimer's disease …
- 102100008476 TREM2 0 title abstract description 29
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Neumann et al. | Variant TREM2 as risk factor for Alzheimer's disease | |
| Morris et al. | FOXO3: a major gene for human longevity-a mini-review | |
| Ozelius et al. | LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews | |
| Janowski et al. | Intravenous route of cell delivery for treatment of neurological disorders: a meta-analysis of preclinical results | |
| Majounie et al. | Repeat expansion in C9ORF72 in Alzheimer's disease | |
| Zimetti et al. | Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease | |
| Waisman | To be 17 again—Anti–interleukin-17 treatment for psoriasis | |
| Rodriguez | A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis | |
| Wolf et al. | Anti-IL-36R antibodies, potentially useful for the treatment of psoriasis: a patent evaluation of WO2013074569 | |
| Han et al. | Contributions of triggering-receptor-expressed-on-myeloid-cells-2 to neurological diseases | |
| Wang et al. | Mannitol cannot reduce the mortality on acute severe traumatic brain injury (TBI) patients: a meta–analyses and systematic review | |
| Cavo et al. | The changing landscape of myeloma therapy | |
| Doroshow | Targeting EGFR in non–small-cell lung cancer | |
| Akai et al. | De novo aneurysm formation following gamma knife surgery for arteriovenous malformation: a case report | |
| Greene | Deep-brain stimulation for generalized dystonia | |
| Di Nunno et al. | How to treat histone 3 altered gliomas: Molecular landscape and therapeutic developments | |
| Beckers et al. | Adult final height after GH therapy for irradiation-induced GH deficiency in childhood survivors of brain tumors: the Belgian experience | |
| Tatum et al. | Onco-epilepsy: more than tumor and seizures | |
| Williams | Broadening the indications for hematopoietic stem cell genetic therapies | |
| Martin et al. | Myositis ossificans | |
| Rubino et al. | Three novel missense mutations in SLC20A2 associated with idiopathic basal ganglia calcification | |
| Ohyama et al. | A novel missense mutation of the STS gene in two siblings with X‐linked ichthyosis, complicated by short stature, bone density reduction, epilepsy, and cryptorchidism | |
| Petrák et al. | Neurofibromatosis von Recklinghausen type 1 (NF1)-clinical picture and molecular-genetics diagnostic | |
| Baricordi et al. | In rheumatoid arthritis, a polymorphism in the HLA-G gene concurs in the clinical response to methotrexate treatment | |
| Aronin et al. | Hunting down huntingtin |